126 related articles for article (PubMed ID: 36101928)
1. Tacrolimus Population Pharmacokinetic Model in Adult Chinese Patients with Nephrotic Syndrome and Dosing Regimen Identification Using Monte Carlo Simulations.
Liao M; Wang M; Zhu X; Zhao L; Zhao M
Ther Drug Monit; 2022 Oct; 44(5):615-624. PubMed ID: 36101928
[TBL] [Abstract][Full Text] [Related]
2. Dosage Optimization Based on Population Pharmacokinetic Analysis of Tacrolimus in Chinese Patients with Nephrotic Syndrome.
Lu T; Zhu X; Xu S; Zhao M; Huang X; Wang Z; Zhao L
Pharm Res; 2019 Feb; 36(3):45. PubMed ID: 30719576
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.
Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X
J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and dosage optimization of tacrolimus in pediatric patients with nephrotic syndrome
.
Wang X; Han Y; Chen C; Ma L; Xiao H; Zhou Y; Cui Y; Wang F; Su B; Yao Y; Ding J
Int J Clin Pharmacol Ther; 2019 Mar; 57(3):125-134. PubMed ID: 30663980
[TBL] [Abstract][Full Text] [Related]
5. Optimization of initial dosing scheme of tacrolimus in pediatric refractory nephrotic syndrome patients based on CYP3A5 genotype and coadministration with wuzhi-capsule.
Chen X; Wang DD; Xu H; Li ZP
Xenobiotica; 2020 May; 50(5):606-613. PubMed ID: 31530218
[TBL] [Abstract][Full Text] [Related]
6. Dosage optimization of tacrolimus based on the glucocorticoid dose and pharmacogenetics in adult patients with systemic lupus erythematosus.
Wang CB; Zhang YJ; Zhao MM; Zhao L
Int Immunopharmacol; 2023 Nov; 124(Pt A):110866. PubMed ID: 37678026
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetic Analysis of Tacrolimus in Adult Chinese Patients with Myasthenia Gravis: A Prospective Study.
Liu J; Guo YP; Jiao Z; Zhao CB; Wu H; Li ZR; Cai XJ; Xi JY
Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):453-466. PubMed ID: 32170643
[TBL] [Abstract][Full Text] [Related]
8. Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome.
Li L; Zhu M; Li DY; Guo HL; Hu YH; Xu ZY; Jing X; Chen F; Zhao F; Li YM; Xu J; Jiao Z
Int Immunopharmacol; 2021 Sep; 98():107827. PubMed ID: 34284341
[TBL] [Abstract][Full Text] [Related]
9. Effect of drug combination on tacrolimus target dose in renal transplant patients with different
Zhang SF; Tang BH; Wei AH; Du Y; Guan ZW; Li Y
Xenobiotica; 2022 Mar; 52(3):312-321. PubMed ID: 35395919
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of tacrolimus in children with nephrotic syndrome.
Hao GX; Huang X; Zhang DF; Zheng Y; Shi HY; Li Y; Jacqz-Aigrain E; Zhao W
Br J Clin Pharmacol; 2018 Aug; 84(8):1748-1756. PubMed ID: 29637588
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model.
Huang L; Liu Y; Jiao Z; Wang J; Fang L; Mao J
Eur J Pharm Sci; 2020 Feb; 143():105199. PubMed ID: 31862313
[TBL] [Abstract][Full Text] [Related]
12. Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule.
Chen X; Wang D; Xu H; Li Z
J Clin Pharm Ther; 2020 Apr; 45(2):309-317. PubMed ID: 31755126
[TBL] [Abstract][Full Text] [Related]
13. Impact of Donor and Recipient
Shao J; Wang C; Fu P; Chen F; Zhang Y; Wei J
Ann Pharmacother; 2020 Jul; 54(7):652-661. PubMed ID: 31888346
[No Abstract] [Full Text] [Related]
14. Population pharmacokinetics and dosage optimisation of tacrolimus coadministration with Wuzhi capsule in adult liver transplant patients.
Du Y; Song W; Xiong X; Ge W; Zhu H
Xenobiotica; 2022 Mar; 52(3):274-283. PubMed ID: 35502774
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
[TBL] [Abstract][Full Text] [Related]
16. Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study.
Wang DD; Chen X; Li ZP
J Clin Pharm Ther; 2019 Aug; 44(4):611-617. PubMed ID: 30864229
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review.
Wang CB; Zhang YJ; Zhao MM; Zhao LM
Eur J Clin Pharmacol; 2023 Jul; 79(7):897-913. PubMed ID: 37261481
[TBL] [Abstract][Full Text] [Related]
18. Initial Dosage Optimization of Tacrolimus in Pediatric Patients With Thalassemia Major Undergoing Hematopoietic Stem Cell Transplantation Based on Population Pharmacokinetics.
Zhou S; Zhang R; Lv C; Lu J; Wei Y; Li C; Chen M; Li Q; Liu T
Ann Pharmacother; 2021 Apr; 55(4):440-451. PubMed ID: 32924532
[TBL] [Abstract][Full Text] [Related]
19. Initial dosage optimization of tacrolimus in Chinese pediatric patients undergoing kidney transplantation based on population pharmacokinetics and pharmacogenetics.
Chen X; Wang DD; Xu H; Li ZP
Expert Rev Clin Pharmacol; 2020 May; 13(5):553-561. PubMed ID: 32452705
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients.
Cai X; Song H; Jiao Z; Yang H; Zhu M; Wang C; Wei D; Shi L; Wu B; Chen J
Eur J Pharm Sci; 2020 Sep; 152():105448. PubMed ID: 32621968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]